JAK2 and myeloproliferative disorder: Arguably one of the most important discoveries communicated at this year’s ASH was in the field of myeloproliferative neoplams (MPN), where an unresolved issue was the identity of mutated genes in the cases in which JAK2, the most commonly mutated gene, is wild type [13].